Advanced search
Add to list

Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.

(2008) EJC SUPPLEMENTS. 6(12). p.31-31
Author
Organization

Citation

Please use this url to cite or link to this publication:

MLA
Jacobs, B et al. “Amphiregulin and Epiregulin Expression in Primary Colorectal Cancer Identifies a Subgroup of Patients That Will Respond to EGFR Inhibition.” Ejc Supplements. Vol. 6. 2008. 31–31. Print.
APA
Jacobs, B., Van Oirbeek, R., Biesmans, B., Fieuws, S., De Roock, W., De Schutter, J., Humblet, Y., et al. (2008). Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition. EJC SUPPLEMENTS (Vol. 6, pp. 31–31). Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics.
Chicago author-date
Jacobs, B, R Van Oirbeek, B Biesmans, S Fieuws, W De Roock, J De Schutter, Y Humblet, Marc Peeters, E Van Cutsem, and S Tejpar. 2008. “Amphiregulin and Epiregulin Expression in Primary Colorectal Cancer Identifies a Subgroup of Patients That Will Respond to EGFR Inhibition.” In Ejc Supplements, 6:31–31.
Chicago author-date (all authors)
Jacobs, B, R Van Oirbeek, B Biesmans, S Fieuws, W De Roock, J De Schutter, Y Humblet, Marc Peeters, E Van Cutsem, and S Tejpar. 2008. “Amphiregulin and Epiregulin Expression in Primary Colorectal Cancer Identifies a Subgroup of Patients That Will Respond to EGFR Inhibition.” In Ejc Supplements, 6:31–31.
Vancouver
1.
Jacobs B, Van Oirbeek R, Biesmans B, Fieuws S, De Roock W, De Schutter J, et al. Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition. EJC SUPPLEMENTS. 2008. p. 31–31.
IEEE
[1]
B. Jacobs et al., “Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.,” in EJC SUPPLEMENTS, Geneva, 2008, vol. 6, no. 12, pp. 31–31.
@inproceedings{687891,
  author       = {Jacobs, B and Van Oirbeek, R and Biesmans, B and Fieuws, S and De Roock, W and De Schutter, J and Humblet, Y and Peeters, Marc and Van Cutsem, E and Tejpar, S},
  booktitle    = {EJC SUPPLEMENTS},
  issn         = {1359-6349},
  language     = {eng},
  location     = {Geneva},
  number       = {12},
  pages        = {31--31},
  title        = {Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition.},
  volume       = {6},
  year         = {2008},
}

Web of Science
Times cited: